Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Juhura G, Almazi"'
Publikováno v:
Pharmaceutics, Vol 14, Iss 7, p 1323 (2022)
The exposure of lung epithelium to environmental hazards is linked to several chronic respiratory diseases. We assessed the ability of an inhaled dry powder (DPI) medical device product (PolmonYDEFENCE/DYFESATM, SOFAR SpA, Trezzano Rosa, Italy), usin
Externí odkaz:
https://doaj.org/article/ab995682b5184f608fcf66c850e72342
Autor:
Yuan Zhang, Juhura G. Almazi, Hui Xin Ong, Matt D. Johansen, Scott Ledger, Daniela Traini, Philip M. Hansbro, Anthony D. Kelleher, Chantelle L. Ahlenstiel
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 5, p 2408 (2022)
Since December 2019, a pandemic of COVID-19 disease, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly spread across the globe. At present, the Food and Drug Administration (FDA) has issued emergency approval for
Externí odkaz:
https://doaj.org/article/7261309d9001436e8e82f0bb9b310e06
Autor:
Jacinta H, Martin, Riazuddin, Mohammed, Sarah J, Delforce, David A, Skerrett-Byrne, Celine Corbisier, de Meaultsart, Juhura G, Almazi, Andrew N, Stephens, Nicole M, Verrills, Evdokia, Dimitriadis, Yu, Wang, Eugenie R, Lumbers, Kirsty G, Pringle
Publikováno v:
Oncotarget. 13:587-599
Endometrial cancer is the most diagnosed gynecological malignancy. Despite numerous scientific advances, the incidence and mortality rate of endometrial cancer continues to rise. Emerging evidence suggests a putative role of the (pro)renin receptor (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1875042b56b40367e9eb3862a6a38d8c
https://doi.org/10.18632/oncotarget.28224
https://doi.org/10.18632/oncotarget.28224
Autor:
Sadia Alvi, Daniel P. Poole, Peter McIntyre, Scott Peng, Arisbel B. Gondin, Paulina D. Ramírez-García, Pradeep Rajasekhar, Larissa K. Dill, Simona E. Carbone, Thomas P. Davis, Felix Bennetts, Jeffri S. Retamal, Megan S. Grace, Juhura G. Almazi, Nicholas A. Veldhuis, Nigel W. Bunnett
Publikováno v:
Laboratory Investigation; a Journal of Technical Methods and Pathology
Endothelial and epithelial cells form physical barriers that modulate the exchange of fluid and molecules. The integrity of these barriers can be influenced by signaling through G protein-coupled receptors (GPCRs) and ion channels. Serotonin (5-HT) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::352f5148f2234e1e018f3f3c63eb5cb6
https://doi.org/10.1038/s41374-021-00593-7
https://doi.org/10.1038/s41374-021-00593-7
Autor:
Hubert Hondermarck, Frank Alvaro, Zacary P. Germon, Heather C. Murray, Dominik Beck, Abdul Mannan, Charles E. de Bock, Stephen M. Butler, David A. Skerrett-Byrne, Hayley Flanagan, Matthew D. Dun, Patrick Connerty, Geoff De Iuliis, Jonathan C. Morris, Mengna Chi, Juhura G. Almazi, Hamish D. Toop, Brett Nixon, Ryan J. Duchatel, Sam Faulkner, Janis Chamberlain, Anoop K Enjeti, Callum J Rigby, Richard G. S. Kahl, Jonathan R. Sillar, Nicole M. Verrills
Publikováno v:
Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecf25e7996c11ee55b060a0fd5704258
https://doi.org/10.1038/s41375-020-0814-0
https://doi.org/10.1038/s41375-020-0814-0
Autor:
Juhura G. Almazi, Munther Alomari, Larissa Belov, O. Giles Best, Yandong Shen, Mark E. Graham, Stephen P. Mulligan, Richard I. Christopherson
Publikováno v:
Nucleosides, nucleotidesnucleic acids. 41(3)
Triple combination FCR (fludarabine, cyclophosphamide and rituximab) is often used as front-line treatment for chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma. Results from our laboratory indicate that 2-FaraAMP (fludarabine) has multip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c8f03cfd1626e6855197bf152900462
https://pubmed.ncbi.nlm.nih.gov/34886743
https://pubmed.ncbi.nlm.nih.gov/34886743
Autor:
Martin R. Larsen, Simone J. Stanger, Matthew D. Dun, David A. Skerrett-Byrne, Ilana R. Bernstein, Hanah M Hart, Amanda L. Anderson, Wei Zhou, M Fairuz B Jamaluddin, Geoffry N. De Iuliis, Elizabeth G. Bromfield, Andrea Mathe, Juhura G. Almazi, Brett Nixon
Publikováno v:
Nixon, B, De Iuliis, G N, Hart, H M, Zhou, W, Mathe, A, Bernstein, I, Anderson, A L, Stanger, S J, Skerrett-Byrne, D A, Jamaluddin, M F B, Almazi, J G, Bromfield, E G, Larsen, M R & Dun, M D 2019, ' Proteomic profiling of mouse epididymosomes reveals their contributions to post-testicular sperm maturation ', Molecular and Cellular Proteomics, vol. 18, no. Suppl. 1, pp. S91-S108 . https://doi.org/10.1074/mcp.RA118.000946
Molecular & Cellular Proteomics : MCP
Molecular & Cellular Proteomics : MCP
The proteomic composition of extracellular vesicles (epididymosomes) secreted by the mouse epididymis has been determined by applying multiplexed tandem mass tag based quantification coupled with high resolution LC-MS/MS. This analysis confirmed that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54245c5c7a7b53a44de413cf3408e742
https://findresearcher.sdu.dk:8443/ws/files/149800094/Proteomic_profiling_of_mouse_epididymosomes_reveals_their_contributions_to_post_testicular_sperm_maturation.pdf
https://findresearcher.sdu.dk:8443/ws/files/149800094/Proteomic_profiling_of_mouse_epididymosomes_reveals_their_contributions_to_post_testicular_sperm_maturation.pdf
Autor:
Martin R. Larsen, Heather C. Murray, Nathan D. Smith, Hayley Flanagan, David A. Skerrett-Byrne, Anoop K Enjeti, Richard G. S. Kahl, Charles E. de Bock, Matthew D. Dun, Juhura G. Almazi, Nicole M. Verrills
Publikováno v:
Blood. 136:12-12
*These authors contributed equally to this work Background:Acute Myeloid Leukaemia (AML) is the most common and aggressive form of acute leukaemia, with a 5-year survival rate of just 24%. Activating mutations in the receptor tyrosine kinase FLT3 are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::300f0c4a2a09f3649131ac739b4cdbe3
https://doi.org/10.1182/blood-2020-142435
https://doi.org/10.1182/blood-2020-142435
Autor:
Juhura G. Almazi, Stephen P. Mulligan, O. Giles Best, Swetlana Mactier, Philippa L. Kohnke, Richard I. Christopherson
Publikováno v:
Nucleosides, Nucleotides and Nucleic Acids. 33:375-383
Fludarabine (2-FaraAMP) is a purine analog that is effective against chronic lymphocytic leukemia (CLL) and non-Hodgkins lymphoma (NHL). For some cases of CLL, 2-FaraAMP as a single agent can clear the blood of leukemia cells, but leukemia stem cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::102c095187d55e155a5f6eba88890214
https://doi.org/10.1080/15257770.2013.863334
https://doi.org/10.1080/15257770.2013.863334
Autor:
Martin J. S. Dyer, Juhura G. Almazi, Oliver Giles Best, Aneela Majid, Dana Pascovici, Pauline Y. Huang, Larissa Belov, Stephen P. Mulligan, Zadie Davis, Richard I. Christopherson
Publikováno v:
Leukemia & Lymphoma. 55:2085-2092
Chronic lymphocytic leukemia (CLL) is clinically heterogeneous. While some patients have indolent disease for many years, 20 – 30% will progress and ultimately die of their disease. CLL may be classifi ed by the Rai or Binet staging system, mutatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3baba9eb0b03040fdcbb77609dab77cc
https://doi.org/10.3109/10428194.2013.867486
https://doi.org/10.3109/10428194.2013.867486